Finance

Lists
4875:TYO
Medicinova Inc
Â¥209.00
-0.48%
(-1.00) 1D
Aug 10, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4875...
Open
Â¥209
High
Â¥213
Low
Â¥207
Mkt. cap
10.55B
Avg. vol.
28.29K
Volume
23.50K
52-wk high
Â¥314
52-wk low
Â¥174
EPS
-Â¥38
Shares outstanding
41.88M
No. of employees
6
Open
Â¥209
High
Â¥213
Low
Â¥207
Mkt. cap
10.55B
Avg. vol.
28.29K
Volume
23.50K
52-wk high
Â¥314
52-wk low
Â¥174
EPS
-Â¥38
Shares outstanding
41.88M
No. of employees
6
News stories
From web sources and news partners
About Medicinova Inc
CEOYuichi Iwaki
Employees6
FoundedSep 26, 2000
HeadquartersLa Jolla, California, United States
SectorBiotechnology
Last report
May 14, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.05 / -$0.06
+23.08%beat
Revenue / Est. (USD)
186.98K / 0.00
+∞%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
134.60K
123.32K
151.74K
186.98K
Cost of goods sold
116.35K
115.27K
146.98K
170.10K
Cost of revenue
116.35K
115.27K
146.98K
170.10K
Research and development expenses
2.19M
1.58M
1.54M
1.26M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.44M
1.81M
1.55M
1.59M
Operating expense
3.63M
3.39M
3.10M
2.85M
Total operating expenses
3.74M
3.50M
3.24M
3.02M
Operating income
-3.61M
-3.38M
-3.09M
-2.84M
Other non operating income
952.00
-10.22K
-5.76K
-3.42K
EBT including unusual items
-3.28M
-3.05M
-2.80M
-2.59M
EBT excluding unusual items
-3.28M
-3.05M
-2.80M
-2.59M
Income tax expense
-
-
5.99K
-
Effective tax rate
-
-
-0.21%
-
Other operating expenses
-
-
-
-
Net income
-3.28M
-3.05M
-2.80M
-2.59M
Net profit margin
-2,437.75%
-2,473.56%
-1,846.78%
-1,383.14%
Earnings per share
-0.07
-
-0.05
-0.05
Interest and investment income
324.96K
340.85K
301.88K
252.96K
Interest expense
-
-
-
-
Net interest expenses
324.96K
340.85K
301.88K
252.96K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.60M
-3.38M
-3.09M
-2.83M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google apps